通过流式细胞术有效检测 Hoechst 侧细胞群
August 23rd, 2024
在这里，我们展示了高功率 375 nm 和 405 nm 激光器可以有效地激发 Hoechst 33342，并作为 355 nm 激光器的可行替代方案进行侧群 （SP） 细胞检测，从而扩大了流式细胞术应用中可用激光器的范围。
我们使用 Hoechst 染色群体方法来检测肿瘤起始细胞。在本文中，我们试图寻找 Hoechst 激励的替代方法。我们发现高功率 375 纳米和 405 纳米激光器可以作为传统 355 毫米激光器的可行替代品。
传统上，Hoechst 染料是用 355 纳米的紫外激光激发的。由于紫外激光器的成本高昂，大多数流式细胞术型号通常不配备紫外激光器。我们的方案扩展了可用于检测 Hoechst 染色的激光器范围。
对于专注于正常和恶性干细胞的研究人员，可以使用更多的流式细胞术模型来检测细胞群细胞。
概述
本研究探索了用于检测肿瘤起始细胞的Hoechst 33342染料的替代激发方法。我们证明了高功率375 nm和405 nm激光可以有效替代传统的355 nm激光，从而扩展了流式细胞术应用的选择。
关键研究组成部分
科学领域
- 流式细胞术
- 细胞检测
- 激光激发技术
背景
- Hoechst 33342常用于识别侧群（SP）细胞。
- 传统的激发依赖于355 nm的UV激光，这很昂贵。
- 流式细胞术需要更多可获得的激光选择。
- 本研究调查了替代激光波长的有效性。
研究目的
- 识别Hoechst染料激发的可行激光替代方案。
- 提高流式细胞术技术的可及性。
- 改善肿瘤起始细胞的检测。
使用的方法
- 比较使用375 nm和405 nm激光对Hoechst染料的激发。
- 评估流式细胞术中的检测效率。
- 评估替代激光的成本效益。
- 实施SP细胞检测的协议。
主要结果
- 375 nm和405 nm激光有效激发Hoechst 33342。
- 这些激光为355 nm激光提供了可行的替代方案。
- 扩展的激光选择可以增强SP细胞检测能力。
- 提出了流式细胞术应用的成本效益解决方案。
结论
- 375 nm和405 nm高功率激光适用于Hoechst激发。
- 这些替代方案可以提高研究环境中的可及性。
- 未来的研究可能探索这些激光在细胞检测中的进一步应用。
常见问题
Executive Industry Relevance
Reliable detection of side population (SP) cells via Hoechst 33342 staining is critical for stem cell and cancer stem cell research in early discovery and translational pipelines. The ability to use high-power 375 nm or 405 nm lasers in place of traditional 355 nm UV lasers expands access to validated SP cell assays across more flow cytometry platforms. This flexibility enhances portfolio-wide target validation and mechanistic de-risking for both normal and malignant stem cell programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust identification of SP cells for functional target validation in stem cell and oncology research.
- Supports mechanistic de-risking by confirming dye efflux properties linked to ABC transporter activity.
- Facilitates predictive confidence in stem cell population assays for portfolio triage.
Screening & Assay Development
- Prepares validated SP cell detection systems for downstream compound screening workflows.
- Improves assay reproducibility and standardization by broadening compatible instrumentation.
- Enables scalable and transferable SP cell assays across multiple flow cytometry models.
Translational & Preclinical Research
- Aligns SP cell detection with disease-relevant models for translational biomarker studies.
- Maintains continuity from early discovery through preclinical validation of stem cell-related targets.
- Reduces risk of technical bottlenecks in cross-site or multi-instrument studies.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling SP cell detection on a wider range of flow cytometers, supporting both early target validation and translational research.
- Discovery Biology: Provides a robust platform for hypothesis testing and pathway clarification in stem cell and cancer biology.
- Screening: Delivers standardized, reproducible SP cell readouts for compound evaluation.
- Analytics: Generates quantitative fluorescence data for comparative analysis of cell populations.
- Translational Research: Ensures biomarker alignment and technical continuity across research phases.
- Enterprise Reuse: Establishes a reusable, instrument-flexible SP cell detection capability for diverse R&D teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in stem cell assays.
- Operational Value: Enhances standardization, reproducibility, and scalability of SP cell detection workflows.
- Strategic Value: Supports better go/no-go decisions and capital efficiency by minimizing technical limitations.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of stem cell and oncology programs.
Implementation Considerations
- Requires expertise in flow cytometry and SP cell gating strategies.
- Needs access to high-power 375 nm or 405 nm lasers and compatible analytical infrastructure.
- Demands cross-team standardization of gating and fluorescence detection protocols.
- May require adaptation for different cell types or model systems.
- Instrument compatibility and laser power must be verified for each platform.
Biopharma FAQs
Chapters in this video
0:00
Introduction
1:14
Staining Mouse Bone Marrow Cells with Hoechst to Detect Side Population Cells by Flow Cytometry
2:22
Flow Cytometry of Hoechst‐Stained Mouse Bone Marrow Cells for Effective Detection of Side Population Using High‐Power 375 nm and 405 nm Lasers
